BioCentury
ARTICLE | Clinical News

Imagent perfluorochemical-based ultrasound contrast agent: ALLP began Phase II testing.

October 14, 1996 7:00 AM UTC

Alliance Pharmaceutical Corp. (ALLP), San Diego, Calif. Product: Imagent perfluorochemical-based ultrasound contrast agent Use: Assess heart function and blood flow, and image damage in other organs S...